Gilead Sues Lupin Over Plans To Produce Generic Tamiflu
Gilead Sciences Inc. hit Lupin Ltd. with a third patent lawsuit in three years Wednesday in Maryland federal court, aiming to halt production of a proposed generic version of Tamiflu, Gilead's...To view the full article, register now.
Already a subscriber? Click here to view full article